
Nancy Bitar
Examiner (ID: 11522, Phone: (571)270-1041 , Office: P/2669 )
| Most Active Art Unit | 2664 |
| Art Unit(s) | 2624, 2669, 2664 |
| Total Applications | 1250 |
| Issued Applications | 1011 |
| Pending Applications | 68 |
| Abandoned Applications | 193 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20232778
[patent_doc_number] => 20250290097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-18
[patent_title] => COMPOSITIONS AND METHODS FOR MODIFYING EUKARYOTIC CELLS
[patent_app_type] => utility
[patent_app_number] => 17/768300
[patent_app_country] => US
[patent_app_date] => 2020-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38641
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17768300
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/768300 | COMPOSITIONS AND METHODS FOR MODIFYING EUKARYOTIC CELLS | Oct 15, 2020 | Pending |
Array
(
[id] => 16598356
[patent_doc_number] => 20210024887
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => Method For Differentiating Pluripotent Stem Cells Into Desired Cell Type
[patent_app_type] => utility
[patent_app_number] => 17/065541
[patent_app_country] => US
[patent_app_date] => 2020-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21269
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17065541
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/065541 | Method for differentiating pluripotent stem cells into desired cell type | Oct 7, 2020 | Issued |
Array
(
[id] => 20227346
[patent_doc_number] => 12415989
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-16
[patent_title] => Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs
[patent_app_type] => utility
[patent_app_number] => 17/039006
[patent_app_country] => US
[patent_app_date] => 2020-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 71
[patent_no_of_words] => 23743
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17039006
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/039006 | Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs | Sep 29, 2020 | Issued |
Array
(
[id] => 16576603
[patent_doc_number] => 20210011004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => METHOD FOR CHANGING CONDITION OF EYELID OF HAIRLESS ANIMAL
[patent_app_type] => utility
[patent_app_number] => 17/034009
[patent_app_country] => US
[patent_app_date] => 2020-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3723
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17034009
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/034009 | Method for changing condition of eyelid of hairless animal | Sep 27, 2020 | Issued |
Array
(
[id] => 17460646
[patent_doc_number] => 20220073951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => SYSTEMS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES
[patent_app_type] => utility
[patent_app_number] => 17/019126
[patent_app_country] => US
[patent_app_date] => 2020-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37896
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17019126
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/019126 | SYSTEMS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES | Sep 10, 2020 | Abandoned |
Array
(
[id] => 17895514
[patent_doc_number] => 20220305176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => BIODEGRADABLE SOFT ELASTOMERS FOR REGENERATIVE ENGINEERING
[patent_app_type] => utility
[patent_app_number] => 17/638905
[patent_app_country] => US
[patent_app_date] => 2020-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4791
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17638905
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/638905 | BIODEGRADABLE SOFT ELASTOMERS FOR REGENERATIVE ENGINEERING | Aug 30, 2020 | Pending |
Array
(
[id] => 18374360
[patent_doc_number] => 20230149439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-18
[patent_title] => RHO-ADRP GENE EDITING-BASED METHODS AND COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/996786
[patent_app_country] => US
[patent_app_date] => 2020-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20746
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17996786
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/996786 | RHO-ADRP GENE EDITING-BASED METHODS AND COMPOSITIONS | Jul 29, 2020 | Pending |
Array
(
[id] => 16422153
[patent_doc_number] => 20200347351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => MODIFIED NK-92 haNK003 CELLS FOR THE CLINIC
[patent_app_type] => utility
[patent_app_number] => 16/937370
[patent_app_country] => US
[patent_app_date] => 2020-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17941
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16937370
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/937370 | Modified NK-92 haNK003 cells for the clinic | Jul 22, 2020 | Issued |
Array
(
[id] => 18996186
[patent_doc_number] => 11913018
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-27
[patent_title] => In vitro production of expanded potential stem cells
[patent_app_type] => utility
[patent_app_number] => 16/925518
[patent_app_country] => US
[patent_app_date] => 2020-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 51
[patent_no_of_words] => 22209
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16925518
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/925518 | In vitro production of expanded potential stem cells | Jul 9, 2020 | Issued |
Array
(
[id] => 18058302
[patent_doc_number] => 20220389388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => AVIAN ENTEROIDS
[patent_app_type] => utility
[patent_app_number] => 17/624428
[patent_app_country] => US
[patent_app_date] => 2020-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11623
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17624428
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/624428 | AVIAN ENTEROIDS | Jul 2, 2020 | Pending |
Array
(
[id] => 16570949
[patent_doc_number] => 20210009955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => METHODS AND PRODUCTS FOR TRANSFECTING CELLS
[patent_app_type] => utility
[patent_app_number] => 16/913315
[patent_app_country] => US
[patent_app_date] => 2020-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23417
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16913315
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/913315 | Methods and products for transfecting cells | Jun 25, 2020 | Issued |
Array
(
[id] => 18478471
[patent_doc_number] => 11692203
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-04
[patent_title] => Methods and products for transfecting cells
[patent_app_type] => utility
[patent_app_number] => 16/913306
[patent_app_country] => US
[patent_app_date] => 2020-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 25
[patent_no_of_words] => 23539
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16913306
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/913306 | Methods and products for transfecting cells | Jun 25, 2020 | Issued |
Array
(
[id] => 17830478
[patent_doc_number] => 20220267782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => NUCLEIC ACID CONSTRUCT COMPRISING 5' UTR STEM-LOOP FOR IN VITRO AND IN VIVO GENE EXPRESSION
[patent_app_type] => utility
[patent_app_number] => 17/596781
[patent_app_country] => US
[patent_app_date] => 2020-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17318
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17596781
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/596781 | NUCLEIC ACID CONSTRUCT COMPRISING 5' UTR STEM-LOOP FOR IN VITRO AND IN VIVO GENE EXPRESSION | Jun 18, 2020 | Pending |
Array
(
[id] => 16343901
[patent_doc_number] => 20200308551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => METHODS FOR PRODUCING HEPATOCYTES
[patent_app_type] => utility
[patent_app_number] => 16/902368
[patent_app_country] => US
[patent_app_date] => 2020-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12876
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16902368
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/902368 | Methods for producing hepatocytes | Jun 15, 2020 | Issued |
Array
(
[id] => 17913518
[patent_doc_number] => 20220315913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => NOVEL CRISPR DNA TARGETING ENZYMES AND SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 17/619165
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27098
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -48
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17619165
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/619165 | NOVEL CRISPR DNA TARGETING ENZYMES AND SYSTEMS | Jun 11, 2020 | Pending |
Array
(
[id] => 16451004
[patent_doc_number] => 20200360430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => EXTRACELLULAR MATRIX COMPOSITIONS FOR THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 16/895732
[patent_app_country] => US
[patent_app_date] => 2020-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17201
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16895732
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/895732 | EXTRACELLULAR MATRIX COMPOSITIONS FOR THE TREATMENT OF CANCER | Jun 7, 2020 | Abandoned |
Array
(
[id] => 16310933
[patent_doc_number] => 20200289671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => PHARMACEUTICAL COMPOSITION COMPRISING AIMP2-DX2 FOR PREVENTING OR TREATING NEURONAL DISEASES AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/890697
[patent_app_country] => US
[patent_app_date] => 2020-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6664
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16890697
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/890697 | Pharmaceutical composition comprising AIMP2-DX2 for preventing or treating neuronal diseases and use thereof | Jun 1, 2020 | Issued |
Array
(
[id] => 17749923
[patent_doc_number] => 20220228128
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-21
[patent_title] => USE OF POXVIRUS WITH AUTOLOGOUS INDUCED PLURIPOTENT STEM CELLS FOR VACCINATION AND DISEASE THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/615018
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8478
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -53
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17615018
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/615018 | USE OF POXVIRUS WITH AUTOLOGOUS INDUCED PLURIPOTENT STEM CELLS FOR VACCINATION AND DISEASE THERAPY | May 28, 2020 | Pending |
Array
(
[id] => 16343894
[patent_doc_number] => 20200308544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => METHODS AND PRODUCTS FOR TRANSFECTING CELLS
[patent_app_type] => utility
[patent_app_number] => 16/869232
[patent_app_country] => US
[patent_app_date] => 2020-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23429
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16869232
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/869232 | Methods and products for transfecting cells | May 6, 2020 | Issued |
Array
(
[id] => 16389426
[patent_doc_number] => 20200330367
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => STEM CELL COMPOSITIONS FOR COSMETIC AND DERMATOLOGIC USE
[patent_app_type] => utility
[patent_app_number] => 16/869394
[patent_app_country] => US
[patent_app_date] => 2020-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19677
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16869394
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/869394 | STEM CELL COMPOSITIONS FOR COSMETIC AND DERMATOLOGIC USE | May 6, 2020 | Abandoned |